Can You Get the Mounjaro Injection on the NHS?

The misconception: anyone can simply get it on the NHS now

Most people searching for the Mounjaro injection on the NHS are working from a reasonable assumption: NICE said yes, so surely GPs are prescribing it. The reality is more layered. NICE's recommendation under TA1026 is conditional on phased rollout, and the criteria in place today are genuinely strict. From June 2025, only adults with a BMI of 40 or above AND four or more of five specific weight-related conditions qualify, those conditions being high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes. Ethnic background thresholds run 2.5 kg/m² lower for South Asian, Chinese, Middle Eastern, Black African and African-Caribbean backgrounds, per NICE guidance.

A second NHS cohort (BMI 35 to 39.9 with four or more of those same conditions) opened in June 2026. A further expansion to BMI 40-plus with three conditions is planned for around March 2027. If you're reading this and your BMI is 32, you have high blood pressure and feel you have a clear case, the current NHS route isn't there yet. That isn't a judgement on your health; it's how phased rollout works.

Even patients who meet the criteria are not guaranteed access. GP practices can opt in to prescribe under the 2026/27 QOF contract, but participation varies by surgery and area. Everyone receiving tirzepatide through the NHS must also engage with wrap-around support (diet coaching and activity programmes) as a condition of the prescription.

How the NHS injection route works in practice

If you do meet the current NHS criteria, the route runs through your GP or a specialist weight management service, depending on your area. Tirzepatide is available as a once-weekly subcutaneous injection, supplied as a pre-filled KwikPen. Treatment begins at a 2.5mg dose (a settling-in dose to help your system adjust) with titration managed by your prescriber over subsequent weeks. You would keep the pen in the fridge at home, ideally somewhere consistent; a lot of people find the fridge door works well as a daily-dose reminder.

NICE's guidance states that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment is reviewed. The NHS also sets a review framework to ensure ongoing clinical oversight. All of this is standard: these are not barriers, they are the architecture of safe prescribing for a medicine that is still under additional MHRA monitoring (it carries a Black Triangle designation). You can read more about what the NHS pathway involves on NHS England's weight management injections guidance.

Where to buy a Mounjaro injection if you don't qualify for the NHS

Private prescription is the legal route for people who don't meet NHS thresholds, don't want to wait, or whose GP surgery isn't yet participating. The licensed eligibility criteria for private prescription are broader: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as prediabetes, hypertension, high cholesterol or obstructive sleep apnoea. BMI alone never decides the outcome, a prescriber considers the full picture.

If you're exploring buying Mounjaro online privately, what matters is that the pharmacy you use is registered with the GPhC. You can check any pharmacy's registration at the GPhC online register, it takes about thirty seconds and it is the single most useful verification step you can take. The MHRA has warned publicly about fake weight-loss pens sold without prescriptions through social media and unverified websites; some counterfeit pens have contained insulin. Price significantly below the market rate and offers that involve no clinical assessment are the clearest red flags.

Understanding the prescription process for tirzepatide helps clarify what a legitimate private route looks like: consultation, clinical review by a qualified prescriber, identity and weight verification, and then dispensing. If you want to go further and buy a tirzepatide injection through a regulated pharmacy, the same principles apply: no shortcuts in a properly run service, and there shouldn't be.

Private vs NHS: choosing the right route for your situation

The decision isn't really NHS-good, private-bad or the reverse. It's about which route is open to you and what matters in your situation. NHS treatment is cost-free at point of care, comes with structured support, and is subject to the same clinical standards. Private treatment is faster, accessible to a wider range of patients, and doesn't require meeting phased cohort criteria. The cost is real, Mounjaro's private pricing has risen significantly since Eli Lilly adjusted list prices from September 2025, and it's worth understanding what any quoted price includes before committing.

A good private clinic or pharmacy will conduct as thorough a clinical assessment as an NHS service. If you'd like to explore whether tirzepatide is clinically suitable for your situation through a private consultation, our online pharmacy process and what it involves is worth a read. You can also look at a more detailed breakdown of NHS eligibility if you want to check where your BMI and health profile sit against the current cohort criteria.

When you're ready, check your eligibility with our prescribers, the consultation is free, and you'll have a clear answer the same day.